Cargando…
Expression of human lambda expands the repertoire of OmniChickens
Most of the approved monoclonal antibodies used in the clinic were initially discovered in mice. However, many targets of therapeutic interest are highly conserved proteins that do not elicit a robust immune response in mice. There is a need for non-mammalian antibody discovery platforms which would...
Autores principales: | Ching, Kathryn H., Berg, Kimberley, Morales, Jacqueline, Pedersen, Darlene, Harriman, William D., Abdiche, Yasmina N., Leighton, Philip A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988971/ https://www.ncbi.nlm.nih.gov/pubmed/31995598 http://dx.doi.org/10.1371/journal.pone.0228164 |
Ejemplares similares
-
Common light chain chickens produce human antibodies of high affinity and broad epitope coverage for the engineering of bispecifics
por: Ching, Kathryn H., et al.
Publicado: (2021) -
Chickens with humanized immunoglobulin genes generate antibodies with high affinity and broad epitope coverage to conserved targets
por: Ching, Kathryn H., et al.
Publicado: (2017) -
Complementary epitopes and favorable developability of monoclonal anti-LAMP1 antibodies generated using two transgenic animal platforms
por: Cameron, Beatrice, et al.
Publicado: (2020) -
A Diverse Repertoire of Human Immunoglobulin Variable Genes in a Chicken B Cell Line is Generated by Both Gene Conversion and Somatic Hypermutation
por: Leighton, Philip A., et al.
Publicado: (2015) -
Harnessing Gene Conversion in Chicken B Cells to Create a Human Antibody Sequence Repertoire
por: Schusser, Benjamin, et al.
Publicado: (2013)